Abbott Labs (NYSE: ABT) has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer.Abbott has had a presence in Russia ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE